Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Long-Term Deferred Tax (2016 - 2023)

BeOne Medicines (BEIGF) has disclosed Long-Term Deferred Tax for 8 consecutive years, with $2.0 billion as the latest value for Q4 2023.

  • Quarterly Long-Term Deferred Tax fell 2.38% to $2.0 billion in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2023, down 2.38% year-over-year, with the annual reading at $2.0 billion for FY2023, 2.38% down from the prior year.
  • Long-Term Deferred Tax for Q4 2023 was $2.0 billion at BeOne Medicines, down from $2.1 billion in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $2.1 billion in Q4 2022, with the low at $30.5 million in Q1 2019.
  • Average Long-Term Deferred Tax over 5 years is $328.5 million, with a median of $66.0 million recorded in 2020.
  • The sharpest move saw Long-Term Deferred Tax soared 155.83% in 2019, then dropped 2.38% in 2023.
  • Over 5 years, Long-Term Deferred Tax stood at $37.9 million in 2019, then soared by 74.07% to $66.0 million in 2020, then soared by 61.98% to $106.8 million in 2021, then soared by 1846.59% to $2.1 billion in 2022, then dropped by 2.38% to $2.0 billion in 2023.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $2.0 billion, $2.1 billion, and $103.4 million for Q4 2023, Q4 2022, and Q2 2022 respectively.